Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 24, 2023
Dedicated supporters at the Heart of the Hutch
Using creativity and passion to support Fred Hutch research in good times and bad
Blood and Marrow Transplant Reunion returns to Fred Hutch
Hundreds gather in Seattle to celebrate life, science and cancer survivorship
Dr. Brenda Sandmaier named president of American Society for Transplantation and Cellular Therapy
Transplant immunotherapy physician-scientist will serve 2022-2023 term
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
Q&A: Returning to school, post-transplant
As schools reopen for in-person learning, what should bone marrow transplant recipients do?
Fundamental proteins that guide embryo development are co-opted by cancer
Researchers discover why some critical DNA-packaging proteins called histones evolve rapidly — and may give cancer a boost
Advances in blood disorders research continue despite COVID-19
Expanding use of CAR T-cell therapies, gene editing lead to insights at virtual annual meeting of the American Society of Hematology
Dr. Stanley Riddell awarded Burke O'Reilly Family Endowed Chair in Immunotherapy
Inspired by child's life-threatening illness, family's gift funds development of next-gen therapies
Tip Sheet: COVID-19 vaccines, COVID-19 and cancer patients, smoking cessation apps, structural racism in medicine – and more
Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Lessons from cancer patients in the time of coronavirus
For the immunocompromised and those with disease, social distancing and uncertainty are a way of life. Daily walks, gratitude and dancing help.
Big gains in bone marrow transplant survival since mid-2000s
Despite older, sicker patients, mortality rate dropped by one-third within 10-year period
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
Try, try again: Can a 2nd dose of CAR T cells succeed when the first fails?
First-of-its-kind study offers early indication of factors linked to increased odds of success for patients out of options
Dr. Cameron Turtle receives Anderson Family Endowed Chair for Immunotherapy
Gift will ‘help new ideas move rapidly toward the patients who need them’
Remembering transplant immunologist Dr. John Hansen
Physician-scientist defined rules for matching bone marrow transplant donors and patients, was a founding father of volunteer donor registries
Leukemia research leader Dr. Fred Appelbaum named ‘Giant of Cancer Care’
Physician-scientist and Hutch VP honored for contributions to research, patient care
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer